OHSU COVID-19 Funding Alerts: Week of April 15, 2021

TEM image of an isolate from the first U.S. case of COVID-19.

OHSU Research and Innovation is compiling a running list of COVID-19 research opportunities. We publish the list every Thursday. A pdf of the list is also available.

Featured Opportunities
Multiple NIH Organizations NOSI: Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake
What: 
Supports research to develop, implement and evaluate brief interventions at RADxSM-UP testing sites to maximize effective outreach, education, communication and facilitate the dissemination and uptake of testing and vaccines in underserved and vulnerable communities
Who should apply: Active grantees on one of the sponsoring organization’s grants
Award:
Up to $300,000/up to one year
Deadline: May 10, 2021, 5 p.m. PT

Multiple NIH Organizations Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (U01 Clinical Trial Optional)
What: Supports research to expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines
Who should apply: Anyone with a research interest in COVID-19 testing disparities
Award: Up to $1.5 million/up to two years
Deadline: July 7, 2021, 5 p.m. PT

NIH

NIH Guidance 
AHRQ Guide Notice on Exception to the Use of the Single IRB Review Requirements During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

NHLBI Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
What: Additional guidance for currently-funded NHLBI K01, K08, K23, and K25 recipients impacted by COVID-19 seeking funded extensions

NIAAA Notice of Clarification of Research Priorities for RFA-AA-21-002 “SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)”, RFA-AA-21-003 “SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)” and RFA-AA-21-004 “SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)”

NIAID Notice to Extend Eligibility for Submission of NIAID K99 /R00 Pathway to Independence Award Applications (and Physician-Scientist K99/R00) due to COVID–related Disruptions
What: NIAID will extend eligibility for submission of K99/R00 applications due to COVID–related disruptions

New this week!
Office of The Director Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic 

Office of The Director Exceptions to Use of a Single IRB During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
What: NIH-funded research studies subject to the 2018 requirements for the Federal Policy for the Protection of Human Subjects and its cooperative research provision and that are ongoing or initially reviewed by the Institutional Review Board during the COVID-19 public health emergency may request an exception to the use of a single IRB

Office of The Director Extended Guidance for Applicants Preparing Applications During the COVID-19 Pandemic
What: Notice to extend the guidance that NIH grant applications should NOT include contingency plans that would outline steps needed to recover from temporary, emergency situations, or institutional return-to-the-workplace plans, resulting from the COVID-19 pandemic

Office of The Director Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: January 2022 Council
See also: Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic
And: Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2021 Councils

Office of The Director Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic
What: Guidance for investigators and institutions preparing NIH grant applications for the May 2021 Council round, beginning with applications submitted for the September 25, 2020 due date

Office of The Director Reminder – Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19
What: Reminder that NIH is providing an opportunity for recipients of NIH Fellowship and NIH Career Development awards who have been impacted by COVID-19 to request no-cost and funded extensions

Office of the Director Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
What: Due to disruptions caused by the COVID-19 pandemic, NIH will be providing up to a two-receipt cycle extension (roughly eight additional months) of eligibility for prospective applicants meeting the requirements for submission of a K99/R00 application from the time period covered by the June/July 2020 due dates through the February/March 2021 due dates. Under normal circumstances, individuals must have no more than four years of postdoctoral research experience to be eligible to apply for a K99/R00 award

NIH Point-of-Care Technology Research Network
NIBIB and NIH POCTRN Fast-Track Program for COVID-19 Test Development and Distribution
What:
 Funding to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities with the help of the Rapid Acceleration of Diagnostics (RADx) technology development program
Who should apply: Anyone with a research interest in diagnostics for SARS-CoV-2
Award: Projects are broken into three phases, and funding amount is dependent upon phase; see FOA for more details
Deadline: Open on a rolling basis

Parent Announcements
PA-18-935 Multiple NIH Organizations Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement –  Clinical Trial Optional)
What: FOA to submit applications for urgent competitive revisions; intended to provide funds for NIH grantees applying to expand the scope of their active grant
Who should apply: Anyone with an active grant from one of the participating organizations who can accomplish their research within the competitive segment of the active award
Award: No minimum or maximum/within duration of the parent award
Deadline: Open dates vary by awarding IC

PA-20-135 Multiple NIH Organizations
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)
What: : FOA to submit applications for emergency competitive revisions; offers NIH grantees additional funds for research responsive to the 2019-nCoV outbreak that falls within the scope of an ongoing grant
Who should apply: Anyone with an active grant from one of the participating organizations, such as the NIAID, who can accomplish their research within the competitive segment of the active award
Award: No minimum or maximum/within duration of the parent award
Deadline: Open dates vary by awarding IC

Applies to PA-18-935
NCI Notice of National Cancer Institute (NCI) Participation in PA-18-935 “Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional)”

NIMH NOSI: NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
NIAAA NOSI: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA

NIMH NOSI regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus
NINDS NOSI: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System  

What: Offers competitive revisions to either active parent grants to expand the scope to address research objectives listed in the notice
Who should apply: Anyone with an active grant from the listed agencies
Award: Dependent upon agency
Deadline: NCI: Not listed; NIMH: Open through May 1, 2021; NIAAA: Open through April 15, 2021; NIMH: Open through April 15, 2021; NINDS: Open through April 15, 2021 

NCI Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis
What: The NCI is considering requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources under certain conditions
Who should apply: Current NCI-funded grantees
Award: Funding amount must be within the existing award budget/for the duration of the pandemic
Deadline: For the duration of the COVID-19 crisis 

NIGMS and SGMRO NOSI: Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy
What: Supports IDeA and NARCH grantees to conduct research that helps understand the causes of vaccine hesitancy and/or tests intervention strategies to increase vaccine uptake in IDeA states and/or the American Indian/Alaska Native communities
Who should apply: Institutional Development Award (IDeA) (P20, P30, and U54) and Native American Research Centers for Health (NARCH) (S06) grantees
Award: Up to $200,000/up to one year
Deadline: April 30, 2021, 5 p.m. PT

NIEHS NOSI: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
What: Supports research to provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility or prevention and intervention strategies
Who should apply: Anyone with a research interest in environmental exposures
Award: Not specified/up to two years
Deadline: Rolling monthly through May 4, 2021

Multiple NIH Organizations NOSI regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
What: Aims to highlight the urgent need for research on SARS-CoV-2 and COVID-19 in individuals with Down syndrome in conjunction with the INCLUDE Project
Who should apply: Currently funded grantees under one of the sponsoring organizations
Award: Up to $1 million/one year
Deadline: July 12, 2021, 5 p.m. PDT

NIGMS NOSI: Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
What: Supports incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive computational models for the spread of SARS-CoV-2 and other related infectious agents
Who should apply: Active NIH grantees
Award: Not limited/no longer than the duration of the parent award
Deadline: Rolling through Dec. 15, 2021

New this week!
NIDA NOSI Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
What: Notice to highlight the urgent need for continued research on the impacts of SARS-CoV-2; NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders
Who should apply: Active NIDA grantees
Award: Up to $200,000/up to two years
Deadline: Rolling through March 31, 2022

Applies to PA-20-135

NIEHS NOSI: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
What: Supports research to provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility or prevention and intervention strategies
Who should apply: Anyone with funding through the NIH Microphysiological Systems Program, microphysiological systems programs from across NIH and SBIR/STTR-supported investigators provided the award involves tissue chips
Award: Not specified/up to two years

Deadline: Rolling monthly through May 4, 2021

New this week!
Multiple NIH Organizations NOSI: Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake
What:
Supports research to develop, implement and evaluate brief interventions at RADxSM-UP testing sites to maximize effective outreach, education, communication and facilitate the dissemination and uptake of testing and vaccines in underserved and vulnerable communities
Who should apply: Active grantees on one of the sponsoring organization’s grants
Award: Up to $300,000/up to one year
Deadline: May 10, 2021, 5 p.m. PT

New this week!
Multiple NIH Organizations NOSI: Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (Emergency Supplement – Clinical Trial Optional)
What: Supports research to expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines
Who should apply: Active research and resource grants, cooperative agreements and small business grantees
Award: Up to $750,000/up to two years
Deadline: May 24, 2021, 5 p.m. PT

NIAID NOSI regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
What: Highlights very specific and limited needs for Competitive Revision applications to active NIAID grants in order to further build the infrastructure that NIAID needs to support the SARS-CoV-2 and COVID-19 research response  
Who should apply: PIs on active NIAID grants
Award:
No more than the annual amount of the current parent award/up to two years
Deadline: Rolling through July 2, 2021 

NCATS NOSI regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
What: Supports research on the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection
Who should apply: Anyone with funding through the NIH Microphysiological Systems Program, microphysiological systems programs from across NIH and SBIR/STTR-supported investigators provided the award involves tissue chips
Award: No more the current amount of the parent award/up to two years
Deadline: Open through Jan. 25, 2022

NCATS NOSI: Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
What: Supports high-priority clinical studies and trials to test therapeutics for COVID-19
Who should apply: Current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients
Award: Not limited/no longer than the duration of the parent award
Deadline: Open through Aug. 16, 2024

FOAs 
NCATS Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)
What: Supports research to repurpose existing therapeutic agents to treat COVID-19 sequelae and associated complications that result from SARS-CoV-2 infections
Who should apply: Anyone with a research interest in repurposing therapeutic agents
Award: Up to $9 million/up to three years
Deadline: Rolling starting Aug. 6, 2020 

NIAID and NIEHS Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) and (U19 Clinical Trial Not Allowed)
What: Supports research to define the mechanisms regulating the establishment, development and maintenance of immunity throughout childhood including the impact of pathogenic or commensal microbes or vaccination against infectious diseases, allergens and environmental pollutants on immune ontogeny and function
Who should apply: Anyone with a research interest in childhood immune development; PIs of the U01 cannot also be PI on the U19 and vice versa
Award: For U01: Up to $2.5 million/up to five years; For U19: Up to $5 million/up to five years
Deadline: LOI due: May 4, 2021; Application due: June 4, 2021, 5 p.m. PT

Multiple NIH Organizations Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)
What: Supports research on the impact of SARS-CoV-2 and associated mitigation efforts on individual, family and community behavior and how subsequent economic disruption affects health outcomes with close attention to underserved and vulnerable populations
Who should apply: Anyone with a research interest in social, behavioral and economic research related to COVID-19
Award: Up to $2.5 million/up to five years
Deadline: LOI due: May 9 and Oct. 8, 2021; Application due: June 9 and Nov. 8 2021, 5 p.m. PT

New this week!
Multiple NIH Organizations Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (U01 Clinical Trial Optional)
What: Supports research to expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines
Who should apply: Anyone with a research interest in COVID-19 testing disparities
Award: Up to $1.5 million/up to two years
Deadline: July 7, 2021, 5 p.m. PT

New this week!
Multiple NIH Organizations Emergency Award: RADx-UP – Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)
What: Supports research to  expand research to understand and address the social, ethical and behavioral implications of COVID-19 testing interventions among underserved and vulnerable populations
Who should apply: Anyone with a research interest in COVID-19 and social, ethical and behavioral implications
Award: Up to $800,000/up to two years
Deadline: July 7, 2021, 5 p.m. PT

Other Notices of Special Interest
NCATS
NOSI: Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
What: Solicits applications for Administrative Supplements to UL1, U01, and R21 awards (through PA-18-591), Collaborative Innovation Awards to U01 and R21 awards (through PAR-19-099 and PAR-19-100, respectively), and Competitive Revisions for UL1 awards for each of the non-administrative supplement awards (through PAR-19-337)
Who should apply: Anyone with an active grant with an activity code listed above from the NCATS
Award: Dependent upon FOA you apply through
Deadline: Dependent upon FOA you apply through

NCATS NOSI: Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)
What: Supports projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial to study SARS-CoV-2 and COVID-19
Who should apply: Specific eligibility not listed
Award: Dependent upon FOA you apply through
Deadline: Dependent upon FOA you apply through 

NIGMS NOSI: Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy
What: Supports research to develop innovative educational resources to increase vaccine confidence and encourage vaccine acceptance, especially among populations with a high level of vaccine hesitancy
Who should apply: Active Science Education Partnership Award (SEPA) (R25) grantees
Award: Up to $50,000/one year
Deadline: April 30, 2021, 5 p.m. PT

NIDA NOSI: Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
What: Supports research focused on individuals with HIV who smoke or vape marijuana, tobacco, cocaine and/or methamphetamine to determine the long-term effects of their use among individuals with HIV and COVID-19
Who should apply: Anyone with a research interest in COVID-19 and HIV-positive individuals with substance use disorders
Award: Dependent upon FOA you apply through
Deadline: Open from May 5, 2021 through Sept. 7, 2024

NINDS Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations
What: Supports research on the effects of COVID-19 on the development of or disease progression in Alzheimer’s Disease-Related Dementias
Who should apply: Active NINDS grantees with a research interest in ADRD populations and COVID-19
Award: Up to $1.332 million/up to two years
Deadline: May 5, 2021, 5 p.m. PT

NIDA NOSI: Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
What: Supports research focused on studying the long-term neurocognitive consequences of the COVID-19/HIV/SUDs syndemic
Who should apply: Anyone with a research interest in COVID-19 and HIV-positive individuals with substance use disorders
Award: Dependent upon FOA you apply through
Deadline: Open from May 7, 2021 through Sept. 7, 2024

FIC NOSI: Administrative Supplements for COVID-19-Impacted FIC Research Training and Education Awards
What: Supplemental funding from the Fogarty International Center for active research training and education awards (e.g., D43, U2R, R25) that are in the last year of funding and have been significantly impacted by the COVID-19 pandemic
Who should apply: Active FIC research training and education awardees
Award: Up to $50,000/one year
Deadline: May 14, 2021, 5 p.m. PT

FIC NOSI: Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income Countries
What: Supplemental funding from the Fogarty International Center for active FIC awards (i.e., not awards administered by other NIH ICs with FIC co-funding) to support COVID-19-related research or mentored research projects on scientific questions unique to low- and middle-income countries
Who should apply: Active FIC grantees with with projects focused on COVID-19 and LMICs
Award: Up to $75,000/one year
Deadline: May 14, 2021, 5 p.m. PT

New this week!
Multiple NIH Organizations NOSI: Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations – RADx-UP Phase II (Emergency Supplement – Clinical Trial Optional)
What: Supports research to expand the scope and reach of RADxSM-UP testing interventions to reduce COVID-19 disparities among underserved and vulnerable populations and address scientific questions on interventions to increase access and uptake of COVID-19 testing given the increasing availability of SARS-CoV-2 vaccines
Who should apply: Active research and resource grants, cooperative agreements and small business grantees
Award: Up to $750,000/up to two years
Deadline: May 24, 2021, 5 p.m. PT

NCATS NOSI: Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
What: Administrative supplements from current Clinical and Translational Science Award UL1 component award recipients from these FOAs: PAR-18-940, PAR-18-464, PAR-15-304 and RFA-TR-14-009
Who should apply: Current Clinical and Translational Science Award UL1 component award recipients
Award: Up to $60,000/one year
Deadline: Rolling through June 1, 2021

NIA NOSI: Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration
What: Supports basic and clinical mechanistic research on neurological and neurocognitive sequelae originating from SARS-CoV-2 infection and COVID-19 in aging and age-related neurodegeneration
Who should apply: Anyone with a research interest in COVID-19 and aging and age-related neurodegeneration
Award: Dependent upon FOA you apply through
Deadline: Open from June 5, 2021 through May 7, 2023

NIDA NOSI: Effects of smoking and vaping on the risk and outcome of COVID-19 infection
What: Supports research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection
Who should apply: Anyone with a research interest in COVID-19 and smoking and vaping
Award: Dependent upon FOA you apply through
Deadline: Open from June 5, 2021 through Sept. 7, 2024

NIDCR NOSI: NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)
What:
Supports research studies focused on the physiological involvement of oral cavity and oral manifestations related to SARS-CoV-2 and/or COVID-19
Who should apply: Anyone with a research interest in COVID-19 and the oral cavity
Award: Dependent upon FOA you apply through
Deadline: Open from June 5, 2021 through May 8, 2023

NIAID NOSI on Pan-Coronavirus Vaccine Development Program Projects
What: Supports research that incorporates understanding of CoV virology and immunology, immunogen design and vaccine and adjuvant platforms and technologies to discover, design and develop pan-coronavirus vaccine candidates that provide broad protective immunity to multiple CoV strains
Who should apply: Anyone with a research interest in pan-coronavirus vaccines
Award: Not limited/up to five years
Deadline: June 11, 2021

NIAMS Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
What: Encourages basic, translational, pre-clinical and clinical observational research focused on COVID-19 infection and its intersection with rheumatic, musculoskeletal, and skin diseases and conditions
Who should apply: Anyone with a research interest in COVID-19 and diseases within the NIAMS mission
Award: Dependent upon FOA you apply through
Deadline: Open  through Nov. 18, 2021

Multiple NIH Organizations NOSI: Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
What: Supports research strategies and interventions to address vaccine hesitancy, uptake and implementation among populations who experience health disparities in the US
Who should apply: Anyone with a research interest in vaccine hesitancy
Award: Not limited/up to five years
Deadline: Open through Jan. 8, 2022

NCATS NOSI regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
What: Supports research on the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection
Who should apply: Anyone with funding through the NIH Microphysiological Systems Program, microphysiological systems programs from across NIH and SBIR/STTR-supported investigators provided the award involves tissue chips
Award: No more than 25 percent of the total costs of the amount of the parent award/up to one year
Deadline: Open through Jan. 25, 2022

NICHD and NIMH NOSI: COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Children
What: Supports research to understand the mental health impact of the COVID-19 pandemic on school-aged children, specifically ages 3 to 12
Who should apply: Anyone with a research interest in the pandemic’s effect on children’s mental health
Award: Not limited/up to five years  
Deadline: Open through Sept. 8, 2022 

NIDCD NOSI: NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders
What: Supports research on COVID-19 in relation to NIDCD’s scientific programs of hearing, balance, taste, smell, voice, speech and language
Who should apply: Specific eligibility not listed
Award: Dependent upon FOA you apply through
Deadline: Open through Sept. 8, 2022

Multiple NIH Organizations NOSI: Simulation Modeling and Systems Science to Address Health Disparities
What: Supports investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities, including those related to COVID-19
Who should apply: Anyone with a research interest in modeling systems and health disparities
Award: Not limited/up to five years
Deadline: Open through May 8, 2023

NIA NOSI: Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)
What: Supports research on the longer-term effects of COVID-19 on the health and well-being of those infected, those caring for the sick and others whose lives were disrupted by the pandemic and its associated mitigation and prevention strategies
Who should apply: Anyone with a research interest in COVID-19 and behavioral, social and aging research
Award: Dependent upon FOA you apply through
Deadline: Open through May 8, 2023

NICHD Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic
What: Encourages research to address the rehabilitation needs of survivors of COVID-19, understand the impact of disruptions to rehabilitation services caused by the COVID-19 pandemic and associated mitigation actions and understand the social, behavioral, economic, and health impact of the COVID-19 pandemic and the associated mitigation actions on people with physical disabilities
Who should apply: Anyone with a research interest in rehabilitation and COVID-19
Award: Award and duration not specified
Deadline: Open through May 8, 2023

NIMH Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research
What: Supports administrative supplements to cover unanticipated costs caused by the COVID-19 pandemic or related mitigation efforts that could not be covered by rebudgeting existing funds
Who should apply: Investigators and institutions with active NIMH awards that have been significantly impacted by COVID-19
Award: No more than the parent award/no longer than the parent award
Deadline: Open through June 1, 2023

NICHD and ORWH Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract
What: Supports applications proposing cutting-edge research on emerging viral infections including COVID-19 and Zika that are thought to primarily impact non-reproductive sites, at least at initial presentation, but may also affect the male and/or female reproductive tract
Who should apply: Anyone with a research interest in viral infections and reproductive tracts
Award: Dependent upon the parent award you apply through
Deadline: Open through July 16, 2023

NCATS NOSI: Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
What: Supplements for projects that address the COVID-19 Public Health Emergency through Clinical and Translational Science Award Program recipients
Who should apply: Active Clinical and Translational Science Award UL1 component award recipients
Award: No more than the parent award/up to two years
Deadline: Open through Aug. 16, 2024

NIDA NOSI: Effects of smoking and vaping on the risk and outcome of COVID-19 infection
What: Supports research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection
Who should apply: Dependent upon FOA you apply through
Award: Award and duration not specified
Deadline: Open through Sept. 8, 2024 

Other Federal Organizations 

BARDA 
BARDA DRIVe and NIOSH Mask Innovation Challenge: Building Tomorrow’s Mask
What:
Supports the development of innovative masks that can protect Americans from respiratory pathogens such as SARS-CoV-2
Who should apply: Anyone with a research interest in masking improvements
Award: For ideation phase: Up to $10,000/not specified; For prototyping phase: Up to $75,000/not specified
Deadline: April 21, 2021, 2 p.m. PT

BARDA DRIVe EZ-BAA
What: The current EZ-BAA solicitation (BAA-20-100-SOL-0002) includes an Area of Interest on developing technologies for early detection of COVID-19 through monitoring health status
Who should apply: Anyone with a research interest in early detection of COVID-19
Award: Up to $749,000/not specified
Deadline: Rolling through Feb. 3, 2023

NSF
NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
What: Calls for proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19; apply through existing funding opportunities and the  Rapid Response Research funding mechanism
Who should apply: No specific eligibility guidelines; direct proposals either to a program officer managing an NSF program with which the research would be aligned or to rapid-covid19@nsf.gov
Award: Up to $200,000/up to one year for RAPID proposals
Deadline: Open

NSF Rapid Response Research (RAPID)  Funding Mechanism
What: Proposal used when there is a severe urgency with regard to availability of or access to data, facilities or specialized equipment, including quick-response research on natural or anthropogenic disasters and similar unanticipated events
Who should apply: No specific eligibility guidelines; direct proposals either to a program officer managing an NSF program with which the research would be aligned or to rapid-covid19@nsf.gov
Award: Up to $200,000/up to one year
Deadline: Open 

Private Organizations 

COVID-19 Early Treatment Fund Outpatient Trials for Repurposed Drugs
What:
Funds outpatient clinical trials to repurpose existing drugs for effective COVID-19 treatment with the goal of rapidly testing and implementing the use of drugs that have already gone through extensive safety testing and are currently approved and marketed for other indications
Who should apply: Anyone with a research interest in repurposing drugs for COVID-19 treatment
Award: Not specified
Deadline: Not specified

ImpactAssets Stop the Spread COVID Response Program
What: Call to companies and organizations to spur development of PPE for both medical and non-medical use, novel testing solutions, widely-accessible therapeutics and digital health solutions to address the needs of underserved communities and vulnerable populations
Who should apply: Anyone with a research interest in PPE
Award: Not limited
Deadline: Not specified

Oak Ridge National Laboratory Call for Rapid Access Proposals for COVID-19 Research
What: Supports research into the COVID-19 virus and the search for effective diagnostics and therapies through the use of neutron macromolecular crystallography, small angle scattering, reflectometry, spectroscopy and imaging beamlines
Who should apply: Researchers who would like to use these resources should submit a short rapid access proposal, outlining experiment aims and scope
Award: Access to the beamlines at the Spallation Neutron Source (SNS) and High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory
Deadline: Rolling

Robert Wood Johnson Foundation Pioneering Ideas: Exploring the Future to Build a Culture of Health
What: Supports proposals to address any of these four areas of focus: Future of Evidence, Future of Social Interaction, Future of Food and Future of Work; not directly aimed at COVID-19 but proposals can be related to the pandemic
Who should apply: Anyone who wants to research COVID-19 and health equity
Award: No minimum or maximum, average amount $315,031/generally between one to three years
Deadline: Rolling
This organization is on the President’s List; submit a notice of intent form before applying

Multiple organizations The Trinity Challenge
What: Global organizations including the Bill and Melinda Gates Foundation, Facebook and Google granting significant support and awards to the best contributions around pandemic preparedness and response
Who should apply: Anyone with a research interest in pandemic preparedness
Award: Funding drawn from an approximately $13.1 million pool (converted from pounds)
Deadline: April 15, 2021 for independent teams to submit the results of their projects and be considered for a share of the prize fund in the inaugural round

Patient-Centered Outcomes Research Institute What interventions are effective in increasing COVID-19 vaccine confidence and uptake among long-term care workers?
What: Supports projects focused on improving vaccine confidence and uptake, including but not limited to educational, communication and behavioral economics strategies, tools or approaches and system- or organizational-level responses
Who should apply: Anyone with a research interest in long-term care worker vaccine confidence and uptake
Award: Up to $5 million/up to three years
Deadline: May 4, 2021, 2 p.m. PT

Patient-Centered Outcomes Research Institute Engagement Award Special Cycle: Building Capacity for PCOR/CER for Topics Related to COVID-19
What: Supports projects that enable organizations and communities to build their capacity and skills to participate across all phases of the PCOR/CER process on topics that address health outcomes related to COVID-19
Who should apply: Anyone with a research interest in patient-centered research related to COVID-19
Award: Up to $200,000/one and a half years
Deadline: May 24, 2021, 2 p.m. PT 

Leave a Reply